Pricing Log in Create free account

Atossa Therapeutics, Inc. (ATOS) vs BioStem Technologies, Inc. (BSEM)

Atossa Therapeutics, Inc. and BioStem Technologies, Inc. are both Biotechnology companies. Atossa Therapeutics, Inc. and BioStem Technologies, Inc. are of similar size ($20.2M and $19.4M). BioStem Technologies, Inc. grew revenue faster over the last twelve months: −87.1% against −93.7%. Atossa Therapeutics, Inc. has the higher net margin (0.00% vs −76.0%) and the lower return on invested capital (−3,918.8% vs 55.3%). Across the 16 metrics below, BioStem Technologies, Inc. leads on 11 and Atossa Therapeutics, Inc. on 5.

Valuation

Metric ATOS BSEM Biotechnology median
P/E n/m n/m 10.60
P/S 479.89 0.56 9.40
P/B 0.72 0.70 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.18 0.68 0.66
EV/Sales (173.58) 0.36 9.02
Earnings yield (202.89%) (137.92%) (32.88%)
Free cash flow yield (186.04%) 0.00% (23.13%)

Profitability

Metric ATOS BSEM Biotechnology median
Gross margin 0.00% 91.16% 68.51%
Operating margin 0.00% 52.87% 0.00%
Net margin 0.00% (76.02%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (89.23%) 0.00% (51.96%)
Return on assets (77.91%) 0.00% (46.06%)
Return on invested capital (3,918.83%) 55.34% 0.00%

Growth

Metric ATOS BSEM Biotechnology median
Revenue growth (TTM) (93.66%) (87.14%) 6.76%
EPS growth (last fiscal year) (34.73%) (126.53%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ATOS BSEM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.69 0.98 4.97
Net debt to EBITDA 1.12 0.00 1.01

Dividend

Metric ATOS BSEM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATOS BSEM Biotechnology median
Market cap 20.16m 19.42m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack